RTOG 1008: A Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors
To test whether the use of chemotherapy drugs with radiation will improve the results after surgery and radiation alone.
Salivary gland cancer
1. Diagnosis of a malignant major salivary gland tumor or malignant minor
salivary gland tumor of the head and neck
2. Surgical resection with curative intent within 8 weeks prior to registration
3. Age 18+
4. Additional eligibility requirements apply
18 - 99
Healthy Volunteers Needed
Duration of Participation
The treatment phase of the study lasts for 6 to 7 weeks. Follow-up exams will be done 3 months after radiation therapy. Additional follow-ups will be done 6, 9, 12, 18, and 24 months from the start of radiation for the first 2 years, then every 6 months for years 3 and 4, and then once a year for life.
Knight Clinical Trials Information Line